Author: admin

  • Karl McCartney – 2016 Parliamentary Question to the Department of Health

    Karl McCartney – 2016 Parliamentary Question to the Department of Health

    The below Parliamentary question was asked by Karl McCartney on 2016-04-28.

    To ask the Secretary of State for Health, whether his Department’s risk register assesses risks to (a) the provision of health services and (b) changes in the level of the cost of providing health services which result from immigration from (i) other EEA member states and (ii) countries from outside the EEA; and if he will make a statement.

    Jane Ellison

    The Department’s risk management process is used to assess risk across the full range of the Department’s business including the provision of health services and the costs of providing those services.

  • Caroline Lucas – 2016 Parliamentary Question to the Department of Health

    Caroline Lucas – 2016 Parliamentary Question to the Department of Health

    The below Parliamentary question was asked by Caroline Lucas on 2016-04-28.

    To ask the Secretary of State for Health, with reference to paragraph 84 of the Equality Analysis on the new contract for doctors and dentists in training in the NHS, published in March 2016, whether his Department plans to accept the recommendation for amendment of the draft new junior doctor contract to address the position of part-time doctors and advance equality of opportunity between women and men doctors; and if he will make a statement.

    Ben Gummer

    Yes. This is explicit in paragraph 60 of Schedule 2 of the Terms and Conditions of Service published by NHS Employers on 31 March 2016.

    In addition amendments have also been made to the provision for on-call availability with respect to doctors working less than full-time, transitional arrangements have been amended so that doctors who take approved time out of training are not disadvantaged on return to training and so that those doctors who have not completed their training by the end of the transition period (2019/20), because they are working less than full time, or need to take an approved break from training can have the transitional protection period extended by up to three years until August 2022.

  • Catherine West – 2016 Parliamentary Question to the Department of Health

    Catherine West – 2016 Parliamentary Question to the Department of Health

    The below Parliamentary question was asked by Catherine West on 2016-04-28.

    To ask the Secretary of State for Health, what the purpose was of the HIV pre-exposure prophylaxsis stakeholder consultation in January 2016.

    Jane Ellison

    All specialised commissioning policy propositions go through a short period of stakeholder testing to check, amongst other things, whether all relevant evidence has been considered.

  • Peter Dowd – 2016 Parliamentary Question to the Department of Health

    Peter Dowd – 2016 Parliamentary Question to the Department of Health

    The below Parliamentary question was asked by Peter Dowd on 2016-04-28.

    To ask the Secretary of State for Health, what assessment he has made of the effect of changes to local authority social care budgets on the demand for health services.

    Alistair Burt

    The Government is aware of the important link between social care and the health service. This is why it has given local authorities access to up to £3.5 billion of new support for adult social care by 2019/20. This should mean local government has access to the funding it needs to increase social care spending by the end of the Parliament. This funding includes an additional £1.5 billion a year for the Better Care Fund by the end of the Parliament.

    The Better Care Fund creates a local single pooled budget to incentivise the National Health Service and local government to work more closely together, placing people’s wellbeing as the focus of health and care services, and shifting resources into social care and community services for the benefit of the people, communities and health and care systems. Integrated care is the right way to deliver a sustainable health and social care system that can provide better quality care and improve outcomes for individuals.

  • Frank Field – 2016 Parliamentary Question to the Department of Health

    Frank Field – 2016 Parliamentary Question to the Department of Health

    The below Parliamentary question was asked by Frank Field on 2016-04-28.

    To ask the Secretary of State for Health, if his Department will reconsider the Medicines and Healthcare Products Regulatory Authority exemption which prior to 2013 enabled organisations to send surplus medicines to (a) developing countries and (b) other countries outside of the EEA.

    George Freeman

    The Medicines and Healthcare products Regulatory Agency is the government body responsible for the safety and licensing of human medicines in the United Kingdom. The supply of a medicine for human use by way of wholesale requires the holding of a wholesale dealer’s licence. Following the transposition of the European Falsified Medicines Directive, the provisions of which are intended to prevent counterfeit medicines from entering the regulated supply chain, this requirement was extended to the export of medicines outside of Europe by way of wholesale from October 2013. The Directive does not allow any exception or exemption from this requirement.

  • Valerie Vaz – 2016 Parliamentary Question to the Department of Health

    Valerie Vaz – 2016 Parliamentary Question to the Department of Health

    The below Parliamentary question was asked by Valerie Vaz on 2016-04-28.

    To ask the Secretary of State for Health, what (a) oral and (b) written communication, guidance and information there has been between his Department and Health Education England on implementation of changes to junior doctors’ contracts and terms and conditions.

    Ben Gummer

    The Department communicates on a regular basis with Health Education England (HEE) on a wide range of issues including the implementation of the new contract for doctors and dentists in training.

    Departmental officials and I meet on a weekly basis to discuss the implementation of the new contract; the group includes representatives from NHS Employers, HEE and NHS Improvement.

  • Virendra Sharma – 2016 Parliamentary Question to the Department of Health

    Virendra Sharma – 2016 Parliamentary Question to the Department of Health

    The below Parliamentary question was asked by Virendra Sharma on 2016-04-28.

    To ask the Secretary of State for Health, what the remit is of the UK Vaccines Research and Development Network.

    Jane Ellison

    The focus of the UK Vaccine Network is to bring together experts from industry, academia, philanthropy and government to make targeted investments in world-leading vaccine candidates, vaccine platform technology and vaccine manufacturing technology to combat diseases with epidemic potential in low and middle income countries, such as Ebola and Zika.

    The UK Vaccine Network will allocate funding to world leading science in the areas above, and funding awards will only be made following appropriate competitive processes, and rigorous, international expert peer review of all applications. The criteria used as part of individual funding decisions will be decided on a competition by competition basis, following international expert advice.

  • Virendra Sharma – 2016 Parliamentary Question to the Department of Health

    Virendra Sharma – 2016 Parliamentary Question to the Department of Health

    The below Parliamentary question was asked by Virendra Sharma on 2016-04-28.

    To ask the Secretary of State for Health, what criteria the UK Vaccines Research and Development Network will use to allocate funding.

    Jane Ellison

    The focus of the UK Vaccine Network is to bring together experts from industry, academia, philanthropy and government to make targeted investments in world-leading vaccine candidates, vaccine platform technology and vaccine manufacturing technology to combat diseases with epidemic potential in low and middle income countries, such as Ebola and Zika.

    The UK Vaccine Network will allocate funding to world leading science in the areas above, and funding awards will only be made following appropriate competitive processes, and rigorous, international expert peer review of all applications. The criteria used as part of individual funding decisions will be decided on a competition by competition basis, following international expert advice.

  • Graham Allen – 2016 Parliamentary Question to the Home Office

    Graham Allen – 2016 Parliamentary Question to the Home Office

    The below Parliamentary question was asked by Graham Allen on 2016-04-28.

    To ask the Secretary of State for the Home Department, pursuant to the Answer of 28 April 2016 to Question 35297, which officials from which departments attended the meetings of the Inter-Ministerial Group on Child Sexual Abuse; and whether the minutes from previous meetings of that group are made available to hon. Members.

    Karen Bradley

    Officials from the Home Office, Department for Education, Department for Communities and Local Government, Ministry of Justice, Department of Health, Department for Culture Media and Sport, and the Attorney General’s Office have attended meetings of the Inter-Ministerial Group on Child Sexual Abuse. Minutes of the meetings are made available to hon. Members who sit on the Inter-Ministerial Group.

  • Andy Slaughter – 2016 Parliamentary Question to the Home Office

    Andy Slaughter – 2016 Parliamentary Question to the Home Office

    The below Parliamentary question was asked by Andy Slaughter on 2016-04-28.

    To ask the Secretary of State for the Home Department, with reference to the oral contribution of the Minister for Security at the Home Office in the sitting of the Investigatory Powers Bill of 26 April 2016, column 549, PBC (Bill 143) 2015-16, how many details of medical records the security and intelligence services hold; what the definition of medical records was for the purposes of that contribution; and whether the intelligence and security services attain medical records directly from those who hold them.

    Mr John Hayes

    The Investigatory Powers Bill significantly strengthens the safeguards in relation to the security and intelligence agencies’ retention and use of bulk personal datasets through the requirement for warrants subject to the ‘double-lock’ of Secretary of State and judicial approval.

    The security and intelligence agencies do not hold medical records as part of their bulk personal datasets. Medical records are a collection of confidential medical information about the mental or physical health of individuals compiled by a medical professional and held by a medical institution.

    The agencies may only acquire information where it is necessary for the proper discharge of their statutory functions and the retention of each bulk personal dataset is subject to strict handling arrangements to ensure that they are only retained where it is necessary and proportionate to do so.The Government cannot provide further details on the datasets that the agencies hold or how they are acquired as to do so would undermine the agencies’ ability to protect national security and prevent and disrupt serious crime.